Results 11 to 20 of about 746,723 (389)
Hormesis and Endothelial Progenitor Cells [PDF]
Dose-Response, 2022 Hormetic-biphasic dose response relationships are reported herein for human endothelial progenitor cells involving estradiol, nicotine, the anti-diabetic agent pioglitazone, resveratrol, and progesterone.
Edward J. Calabrese PhD
doaj +3 more sources
Neoplasia: An International Journal for Oncology Research, 2006 Cancer, a proliferative disease hallmarked by abnormal cell growth and spread, is largely dependent on tumor neoangiogenesis, with evidence of vascular endothelial dysfunction.
P.K.Y. Goon +4 more
doaj +3 more sources
Endothelial Progenitor Cells in Diabetic Retinopathy [PDF]
Frontiers in Endocrinology, 2014 Diabetic retinopathy (DR) is a leading cause of visual impairment worldwide. Patients with DR may irreversibly lose sight as a result of the development of diabetic macular edema (DME) and/or proliferative diabetic retinopathy (PDR); retinal blood vessel
N. Lois +4 more
semanticscholar +6 more sources
Endothelial Progenitor Cells [PDF]
New England Journal of Medicine, 2003 Vascular endothelial cells form a lining — one cell thick — for all the blood vessels in the body, providing a critical interface between the vessel itself and blood-borne elements.
Takayuki Asahara, Jeffrey M. Isner
+6 more sources
Circulating endothelial progenitor cells [PDF]
British Journal of Cancer, 2005 Angiogenesis research investigates the formation of new blood vessels in wound healing, tumour growth and embryonic development. Circulating, bone marrow-derived endothelial progenitor cells (EPCs) were first described 8 years ago, yet the exact nature of these endothelial precursor cells remains unclear.
Garmy-Susini, B, Varner, J A
+6 more sources
Endothelial Progenitor Cells [PDF]
Annual Review of Medicine, 2005 Endothelial progenitor cells are a circulating, bone marrow–derived cell population that appears to participate in both vasculogenesis and vascular homeostasis. Questions persist regarding their functional characteristics, as well as the precise panel of cell surface markers that uniquely define this newly described progenitor cell population.
Aarif Y, Khakoo, Toren, Finkel
openaire +4 more sources
Mobilizing Endothelial Progenitor Cells [PDF]
Hypertension, 2005 Mobilization of endogenous endothelial progenitor cells (EPCs) from the bone marrow may be an alternative way to increase neovascularization and may be used as therapeutic option for the treatment of ischemic cardiovascular diseases. In this review, we discuss the EPC mobilizing effects of pro-inflammatory cytokines such as granolocyte monocyte colony ...
Alexandra, Aicher +2 more
openaire +2 more sources
Common endothelial progenitor cell assays identify discrete endothelial progenitor cell populations [PDF]
American Heart Journal, 2009 Multiple measures of endothelial progenitor cells (EPCs) have been described, but there has been limited study of the comparability of these assays. We sought to determine the reproducibility of and correlation between alternative EPC assay methodologies.We simultaneously assessed EPC numbers in 140 patients undergoing cardiac catheterization using the
Thomas J, Povsic +5 more
openaire +2 more sources
Human Endothelial Progenitor Cells [PDF]
Cold Spring Harbor Perspectives in Medicine, 2011 Human endothelial progenitor cells (EPCs) have been generally defined as circulating cells that express a variety of cell surface markers similar to those expressed by vascular endothelial cells, adhere to endothelium at sites of hypoxia/ischemia, and participate in new vessel formation.
openaire +4 more sources
Does erythropoietin therapy affect circulating endothelial cells in hemodialysis patients?
Український Журнал Нефрології та Діалізу, 2020 Anemia is a common complication of chronic kidney disease (CKD). The most common cause of anemia in CKD is erythropoietin deficiency; and the most important cause of mortality in CKD patients is atherosclerotic vascular complications which are ...
T. Bulduk +7 more
doaj +1 more source